Cerêve Wins Market Go-Ahead For Insomnia Treatment Device
This article was originally published in The Gray Sheet
Executive Summary
The firm's Sleep System device, indicated for overcoming latency to achieve stage 1 and stage 2 sleep, won FDA de novo clearance on June 6 following clinical trials involving 230 people over 3,800 research nights.